A serum biomarker-based index for predicting progressive pulmonary fibrosis in patients with anti-synthetase syndrome: the LOCCM index
Approximately half of patients with ASyS-ILD presented with fibrotic ILD, among whom approximately one-quarter developed PPF. The LOCCM index is a promising tool for identifying patients with ASyS at risk for PPF development.
Authors
- Chen Zong (ORCID: https://orcid.org/0009-0007-0695-033X)
- Yiran Chen
- Yingfang Zhang (ORCID: https://orcid.org/0000-0002-3363-1832)
- Shiyu Wu (ORCID: https://orcid.org/0000-0002-9080-5069)
- Longyang Zhu
- Xin Lü
- Guochun Wang (ORCID: https://orcid.org/0000-0002-4616-9376)
- Qinglin Peng (ORCID: https://orcid.org/0000-0002-1271-1729)
- Xiaoming Shu (ORCID: https://orcid.org/0000-0001-5425-6157)
- Xinxin Zhang (ORCID: https://orcid.org/0000-0002-9281-4508)
- Chao Sun (ORCID: https://orcid.org/0000-0003-3947-6084)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Respiratory Research
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1186/s12931-025-03414-3
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China-Japan Friendship Hospital